ask="4.49"
ask_size="1400"
average_daily_volume="1716840"
bid="4.12"
bid_size="800"
book_value="2.93"
change="+0.00"
change_from_200_day_moving_average="-1.80"
change_from_50_day_moving_average="0.03"
change_from_52_week_high="-5.79"
change_From_52_week_low="0.49"
change_in_percent="+0.00%"
close="4.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.30"
ebitda="-42.20M"
eps_estimate_current_year="-0.58"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.40"
ex_dividend_date="N/A"
float_shares="93018000"
high="4.36"
high_52_weeks="10.06"
last_trade_date="2/17/2017"
last_trade_price="4.27"
last_trade_size="177000"
last_trade_time="4:00pm"
low="4.17"
low_52_weeks="3.78"
market_capitalization="583.62M"
moving_average_200_day="6.07"
moving_average_50_day="4.24"
name="Achillion Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.05"
open="4.27"
pe_ratio="N/A"
peg_ratio="-0.42"
percent_change_from_200_day_moving_average="-29.61%"
percent_change_from_50_day_moving_average="+0.62%"
percent_change_from_52_week_high="-57.55%"
percent_change_from_52_week_low="+12.96%"
previous_close="4.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.45"
price_per_sales="18.47"
revenue="31.59M"
shares_outstanding="136680000"
short_ratio="7.77"
stock_exchange="NMS"
symbol="ACHN"
volume="1338970"
weeks_range_52="3.78 - 10.06"
